Castle Biosciences, Inc. opened its new 55,000-square-foot laboratory and office facility at 8667 E. Hartford Drive in Scottsdale this month, drawing government officials and community leaders to the Perimeter Center business park for a grand opening celebration. The company develops innovative diagnostic tests designed to guide patient care, and it already employs approximately 220 of its more than 1,000 nationwide team members in the Phoenix metro area. The facility is not just a bigger office. It is evidence that a category of healthcare innovation tied directly to clinical decision-making is choosing Arizona as a place to grow.

What Diagnostic Testing Companies Do for Patient Care

The average patient visiting a dermatologist or specialist in Arizona may not know whether the lab behind their diagnostic results is in their city or three states away. Castle Biosciences is a company whose business sits at the intersection of laboratory science and clinical practice: it develops tests that help physicians make more precise decisions about patient care. The distinction matters because not all diagnostic tests carry the same level of clinical guidance. A basic biopsy tells a physician what tissue looks like under a microscope. A sophisticated molecular diagnostic test can assess biological markers to help a physician determine which treatment path is supported by evidence and when a more conservative approach is medically defensible rather than an oversight.

Chief Operating Officer Kristen Oelschlager described the new facility as providing “additional space, infrastructure and capacity” to support both current operations and future expansion. That operational depth is not incidental. The precision required by diagnostic testing companies is physical as well as scientific. The Scottsdale facility features upgraded HVAC, IT, and security infrastructure with backup power systems, reflecting the reality that lab environments cannot tolerate power disruptions, temperature swings, or security gaps. The investment in that kind of infrastructure signals a long-term commitment, not a convenience location.

Why Scottsdale, and What It Signals for the Arizona Health Economy

The 260-acre Perimeter Center business park is one of Scottsdale’s established hubs for professional and corporate tenants. Choosing it for a 55,000-square-foot laboratory rather than a simple satellite office says something specific about how a health technology company views Arizona’s labor market, infrastructure, and long-term growth potential. With approximately 220 employees already in the Phoenix metro area, Castle Biosciences was operating here at meaningful scale before this opening. This facility deepens that commitment rather than launching it.

Arizona has attracted life science and health technology companies in recent years for reasons that extend beyond cost. The state’s growing university research pipeline, an expanding professional talent base, and a patient population that has grown faster than most states all make it a logical site for companies that need to recruit scientists, clinical liaisons, and operations specialists over the long term. When a company with more than 1,000 employees invests in a new facility with upgraded infrastructure and plans for future expansion, it is signaling a judgment that those conditions are durable.

For the broader Arizona health economy, each step like this raises the floor. As health technology companies grow their local footprints, they generate professional ecosystems: lab scientists, IT and security specialists, clinical liaisons, and operations managers who build careers in the Valley. That talent pool makes the region more attractive to the next company evaluating a significant facility commitment.

What This Means if You Are Choosing a Healthcare Provider in Arizona

For patients in the Phoenix metro area, the more important takeaway is not about the building at 8667 E. Hartford Drive. It is about what a growing local presence in precision diagnostics means for the clinical choices available to them.

When diagnostic testing companies establish serious infrastructure close to a patient population, turnaround times can shorten, access to newer tests can broaden, and clinical teams at local practices can build more direct relationships with the laboratory scientists whose work guides their decisions. The question of which laboratory a physician uses, and whether that lab offers current-generation diagnostic technology, is a legitimate one for patients to raise.

If you are working with a dermatologist, oncologist, or specialist who handles complex diagnoses, asking which diagnostic tests or laboratories they rely on is not an impertinent question. Physicians who use evidence-driven diagnostic tools and can explain their reasoning about treatment choices are practicing at a higher standard than those who rely on the same methods they used five years ago without evaluating newer options.

Arizona is increasingly home to companies at the frontier of diagnostic science. Finding professionals who are connected to that frontier, who are curious about it and incorporate its tools into their practice, is one of the underappreciated ways a patient can raise the quality of their own care. The right professional is not just credentialed. The right professional is current.